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Abstract
An estimated 4–5 million CT scans are performed in the USA every year to investigate 
nephrourological diseases such as urinary stones and renal masses. Despite the clinical benefits of 
CT imaging, concerns remain regarding the potential risks associated with exposure to ionizing 
radiation. To assess the potential risk of harmful biological effects from exposure to ionizing 
radiation, understanding the mechanisms by which radiation damage and repair occur is essential. 
Although radiation level and cancer risk follow a linear association at high doses, no strong 
relationship is apparent below 100 mSv, the doses used in diagnostic imaging. Furthermore, the 
small theoretical increase in risk of cancer incidence must be considered in the context of the 
clinical benefit derived from a medically indicated CT and the likelihood of cancer occurrence in 
the general population. Elimination of unnecessary imaging is the most important method to 
reduce imaging-related radiation; however, technical aspects of medically justified imaging should 
also be optimized, such that the required diagnostic information is retained while minimizing the 
dose of radiation. Despite intensive study, evidence to prove an increased cancer risk associated 
with radiation doses below ~100 mSv is lacking; however, concerns about ionizing radiation in 
medical imaging remain and can affect patient care. Overall, the principles of justification and 
optimization must remain the basis of clinical decision-making regarding the use of ionizing 
radiation in medicine.
Rapid technical advances in CT imaging over the past two decades have enabled an 
increasing number of clinical applications, including CT angiography (CTA) of the 
abdomen1, coronary artery angiography2, and perfusion imaging of the brain3 and heart4, 
providing, in many instances, increased accuracy and reduced invasiveness of diagnostic 
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tests. In nephrourology, CT has become the primary imaging modality for urinary stone 
detection, investigation of painless haematuria, and characterization of renal masses5; CT 
has the highest (>95%) sensitivity and specificity for urinary stone detection of any imaging 
technique, including radiography and ultrasonography6–10. The introduction of 
multidetector-row CT scanners in the late 1990s, which exhibit increased scan coverage and 
temporal resolution compared with single-detector-row scanners, enabled assessment of the 
entire urinary tract in a single breath-hold and multiple phases of contrast enhancement to be 
imaged during a CT urogram11, improving diagnostic accuracy for haematuria12. In 
addition, the development of dualenergy CT scanners enabled discrimination of urinary 
stones on the basis of their chemical composition13, improving the stratification of 
symptomatic patients for medical treatment14.
Increases in the clinical value of CT scanning have meant that the number of CT scans 
performed annually in the USA has increased from approximately 20 million in 1995 to an 
estimated 78.7 million scans in 2015 (REF15), a growth rate of >10% per year15. Although 
CT scans provide 3D information not available from traditional radiography, they require 5–
10 times higher radiation doses than the radiographical techniques commonly used in 
nephrourology16. Thus, the increasing use of CT has raised concerns over the potential risks 
associated with exposure to ionizing radiation17,18.
In this Review, we summarize the potential risks of the low doses (<100 mSv) of ionizing 
radiation associated with CT imaging and describe the beneficial uses of CT for urological 
diseases or injury. Finally, we discuss the state-of-the-art techniques in use to appropriately 
manage the amount of radiation required for effective CT imaging.
Radiation exposure and risk
In 2001, a paper was published that calculated a potential increased lifetime cancer risk after 
childhood CT imaging19. Since then, several papers have similarly hypothesized that the 
doses of ionizing radiation associated with medical imaging exams, and CT in particular, 
might lead to an increased lifetime risk of cancer20–22. In these articles, a small upper bound 
estimation of risk, mainly derived from atomic bomb survivor data, is multiplied by the large 
number of patients undergoing CT examinations to yield estimates for potential future 
cancer incidence and mortality (typically an approximate 0.05–2% increase in incidence 
risk)18,23. These reports have received considerable media attention24,25, with one possible 
consequence being a delay or deferral of necessary medical imaging owing to the concerns 
of patients and/or referring physicians. In a study of 100 child-hood patients undergoing 
nonurgent CT examinations, Larson et al.26 reported that merely providing appropriate risk 
information increased the level of parental concern in 14% of cases, although no parent 
ultimately refused for their child to undergo a medically indicated scan. However, in 
circumstances in which observation was deemed a safe alternative, the number of parents 
who would prefer to avoid the CT scan in favour of surveillance increased from 20% to 
37%26. In a larger study with 742 parents enrolled, Boutis et al.27 reported that the number 
of parents willing to allow their child to undergo a head CT examination decreased from 
90% to 70% following patient education on the potential associated risks. Notably, in 5.6% 
of cases (42 of 742), the parents refused a clinically recommended head CT examination, 
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which could pose a potentially greater risk to paediatric patients than the radiation exposure 
from the imaging, as traumatic brain injury is the leading cause of death in children in the 
USA28.
Understanding radiation exposure risk
An understanding of the mechanisms of radiation damage and repair is essential to 
understand the potential risk of harmful biological effects from exposure to ionizing 
radiation. Several models exist to describe the dose-response relationship, the shape of 
which is uncertain at low doses29 (FIG. 1). Low-dose radiation has been defined by the 
United States National Research Council as doses in the range from ~0 mSv to ~100 mSv 
(0.1 Sv) of low-linear-energy-transfer radiation (for example, X-rays)17. Despite these 
uncertainties, a general consensus exists in the radiation biology, epidemiology, and 
protection communities that, at low doses, the magnitude of harmful effects is very small 
and might, in fact, be zero17. That radiation is carcinogenic at high doses is clear17, but this 
effect has not been demonstrated to be true at the low doses of ionizing radiation used in 
medical imaging.
Biological effects of radiation
For long-term effects, such as cancer induction, the risks from exposure to ionizing radiation 
are inherently random; the probability of damage (for example, carcinogenesis) increases 
with the dose of radiation received, but the severity of the damage is independent of the dose 
received. This type of biological damage is associated with the potential replication of cells 
whose genetic information has been physically compromised by the local deposition of 
energy and the subsequent breaking of chemical bonds, for example, double-strand breaks in 
the DNA induced by radiation30. If this physical damage is not recognized by the cell, 
triggering repair or self-kill mechanisms, mutations resulting in uncontrolled replication 
might occur over time, causing cancer30.
Starting at absorbed doses above ~2,000 mSv, the overall risk from ionizing radiation shifts 
from random, long-term effects to acute, short-term effects, such as skin reddening, skin 
burns, and/or hair loss. These short-term effects can arise hours to weeks after long 
interventional procedures using X-ray fluoroscopy imaging (such as a cardiac 
catheterization). For skin doses >6,000 mSv, the possibility of radiation-induced erythema 
and epilation requires monitoring of the skin in the weeks following the intervention31. At 
doses to the skin of >15,000 mSv, the effect becomes more severe and can lead to deep 
ulcerous lesions that are difficult to heal. Except for very rare incidents associated with gross 
medical error32, the doses used in CT imaging will not result in short-term effects. In almost 
five decades of the use of CT in medicine, only a handful of such medical errors have been 
reported.
Magnitude of cancer risk at low doses
The majority of data regarding the carcinogenic effects of ionizing radiation in humans are 
derived from atomic bomb survivor cohorts17,33–36. These data reveal an approximately 
linear trend of excess cancer risk of solid tumours and a quadratic trend of excess risk of 
leukaemia for increasing single radiation exposures of effective doses above ~150 mSv, but 
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show no statistically significant increase in cancer risk below an effective dose of 100 mSv 
from a single irradiation17,36 (FIG. 2). Notably, the exposure conditions and the exposed 
population in atomic bomb survivor studies differ markedly from those of patients 
undergoing medical imaging, limiting the generalizability of these data. For example, atomic 
bomb exposures were delivered in a fraction of a second and included a radiation dose from 
neutrons and by-products of the nuclear reaction37. By contrast, medical radiation is 
typically delivered over seconds to hours and involves primarily photon radiation such as X-
rays and gamma rays38. Additionally, populations exposed to atomic bomb detonations were 
exposed to numerous other carcinogenic factors, such as asbestos from the destruction of 
buildings39. However, despite their limitations, these data from >70 years of following the 
atomic bomb survivor cohort17,33–36 are still used as the foundation of most radiation risk 
estimates.
Long-term risks due to exposure to ionizing radiation exposures from medical imaging have 
been specifically investigated, with contradictory outcomes. In particular, two studies of 
children who received CT scans suggested that these patients are at increased risk of 
subsequent cancer, sparking considerable controversy21,40. Pearce and colleagues21 
retrospectively analysed >200,000 patients in the UK who underwent one or more CT scans 
before the age of 22 years and noted a positive association between radiation dose from CT 
scans and excess relative risk of both leukaemia and brain tumours. Similarly, Mathews et al.
40
 studied >680,000 Australian patients who received one or more CT scans before 19 years 
of age and noted an overall excess risk of any type of cancer of 24% compared with that of 
an unexposed population. Crucially, these observational studies lacked a proper control 
cohort, did not perform individual dose estimates for each subject, and did not consider that 
the underlying injury or disease that prompted the CT scan might be the cause of the 
observed associations. For example, both glioma and meningioma have been reported to 
form at the exact location of a previous brain injury, as verified by CT or MRI41,42. Thus, 
the injury itself might be the causative factor, and the resulting tumour might be incorrectly 
attributed to the radiation from CT. Moreover, some of the findings were inconsistent with 
well-established knowledge of radiation biology and epidemiology, including the observed 
increased risk of melanoma, which one would not expect to arise from deeply penetrating X-
rays and gamma rays; increased risk of cancers in nonirradiated locations, such as the chest, 
abdomen, or pelvis, after head CT scans; increased risk in older versus younger children, 
when young children have long been found to be more radiosensitive; and a lack of 
increased risk of leukaemia and breast cancer after radiation, when these cancers have long 
been associated with increased radiation sensitivity. A follow-up study that attempted to 
address some of these limitations in the UK cohort has been published43 and showed that 
although some residual cancer risk remained after the reanalysis, bias was a substantial 
contributor to the original risk estimates derived in the work by Pearce et al.21.
A 2015 study by Journy and colleagues44 involving a large cohort of >65,000 French 
children demonstrated that cancer-predisposing factors affected the assessment of radiation-
related risk. With proper adjustment for these predisposing factors, no significant excess 
relative risk was observed in relation to CT exposures, with confidence intervals for all 
tumours including the null value44. Thus, the authors concluded that the indication for the 
CT examinations should be considered in similar types of population studies, in order to 
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avoid over estimation of the cancer risks associated with CT scans44. Another large cohort of 
~45,000 German children that received >1 CT scan between 1980 and 2010 produced results 
similar to those of Journy and colleagues44,45, reporting elevated (but not statistically 
significant) standardized incidence ratios for either leukaemia or solid tumours (that is, the 
confidence intervals for the excess relative risk included 0). The reason for the excess in 
observed cancer cases compared with the expected numbers from a control population was 
identified by the authors as the presence of cancer-predisposing factors, such as Down 
syndrome, in those children undergoing CT examinations, consistent with the results from 
the Journy cohort44,45. Both studies were potentially limited by the relatively short follow-up 
period of 4 years, although the studies by Pearce et al. and Mathews et al. similarly used 
short follow-up periods (~10 years for each, on average)21,40. These relatively short follow-
up periods reflect, in part, a desire of the investigators to use recent population cohorts in 
order to be relevant to current CT technology. Ideally, one would use a follow-up period of 
decades for radiation epidemiological studies, as radiation-induced cancers can arise up to 
four decades after exposure. However, in order to do that, one would have to use very old 
data, collected when CT technology was very different from current standards, when the 
dose metrics used were different from those used today and were rarely recorded, and when 
medical records and cancer registries were not electronic, making accurate epidemiological 
analyses of such older data an impossible task.
Atomic bombs and background radiation: limitations of the data.—The 
controversy surrounding the magnitude of any long-term cancer risk from the low doses of 
radiation delivered during typical medical imaging examinations arises from our inability to 
confidently measure such low levels of risk from current epidemiological studies. For 
example, the studies of Journy23 and Krille24 examined >100,000 patients who had received 
>1 CT scan and together reported only 112 cases of cancer (0.11%). For reference, the 
British Journal of Cancer reports that 50% of the population born since 1960 in the UK will 
be diagnosed with cancer at some point in their lifetime46. In fact, an epidemiological study 
including >5 million people would be needed to demonstrate an increased cancer risk from 
exposures to effective doses <10 mSv (which is similar in magnitude or higher than most CT 
scans), with controls needed for all the many potentially confounding variables21,40,47–50.
Furthermore, data from the cohort of atomic bomb survivors, and many of the other studies 
assessing cancer risk after medical CT, involve only a single exposure to radiation. However, 
many patients are exposed multiple times. The linear non-threshold hypothesis operates on 
the premise that the risk from each exposure is independent of all other exposures17; thus, 
the risks from multiple medical exposures are probably not additive. Biological evidence to 
support this position has been obtained from studies of chromosomal damage. For example, 
Lobrich and colleagues51 reported that excess double-strand DNA breaks induced by CT 
imaging are fully repaired after 24 hours, providing tangible evidence that radiation damage 
can be repaired and, therefore, that multiple exposures are not additive. Interestingly, after 
24 hours, the number of double-strand breaks fell to a level below the pre-irradiation 
measurement.
Medical imaging is not the only source of low-level exposure to ionizing radiation. Natural 
background sources include cosmic and terrestrial radiation, as well as ingestion and 
Ferrero et al. Page 5
Nat Rev Urol. Author manuscript; available in PMC 2019 April 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
inhalation of radioactive isotopes, such as radon gas. The magnitude of radiation exposure 
received annually from naturally occurring sources of radiation (1–20 mSv, depending on 
the geographical location) is comparable to the radiation dose associated with a CT scan 
(approximately 1–14 mSv)52. Thus, variations in radiation exposure from naturally 
occurring sources are of similar magnitude to ≥1 CT scans a year, yet no evidence of 
increased cancer incidence exists in areas of the world characterized by high or very high 
levels of naturally occurring ionizing radiation (even at levels well above 200 mSv)17.
Occupational exposure in the nuclear power industry has also been extensively investigated. 
A total of 6 large cohort studies, with a combined study population of >500,000 subjects 
who received cumulative doses of 30–60 mSv and with >30 years of follow-up monitoring, 
revealed that in most cases, rates for all causes and all cancer mortality in the workers were 
substantially lower than those in the reference populations17. A 2016 review of mortality in 
US radiologists found no evidence of excess cancer death rates compared with a control 
population (US psychiatrists) among radiologists who graduated after 1940 (REF53).
Overall, decades of evidence on the effects of human exposure to levels of ionizing radiation 
<100 mSv from natural, occupational, and medical sources do not support the conclusion 
that the level of ionizing radiation associated with CT examinations poses any risk to 
patients.
The linear non-threshold hypothesis
The fundamental uncertainty regarding cancer risk estimation is the assumption that risk is 
linearly proportional to radiation dose. Referred to as the linear non-threshold (LNT) 
hypothesis17, this assumption has often been used in studies that have attempted to quantify 
the detrimental effect of ionizing radiation from medical imaging modalities in terms of 
additional cancer incidence and mortality. However, the radiation biology, epidemiology, and 
protection communities agree that this assumption should not be used to estimate future 
cancers, owing to the large uncertainties in the data at low doses17,54–59.
Statements from independent bodies.—Several independent organizations warn 
against the use of risk estimates tabulated for doses >100 mSv when estimating potential 
risks for low doses17,54–59 (TABLE 1). For instance, the United States National Research 
Council stated in their Committee on the Biological Effects of Ionizing Radiation (BEIR) 
VII report that “...at relatively low doses, there is still uncertainty as to whether there is an 
association between radiation and disease, and if there is an association, there is uncertainty 
about whether it is causal or not”17. Similarly, in its 2010 Summary of Low-Dose Radiation 
Effects on Health, the United Nations Scientific Committee on the Effects of Atomic 
Radiation concluded that “Statistically significant elevations in risk are observed at doses of 
100 to 200 mGy and above. Epidemiological studies alone are unlikely to be able to identify 
significant elevations in risk much below these levels”54.
Putting radiation risk into perspective
Data derived from follow-up monitoring of World War II atomic bomb survivors show that 
the cancer risk from low doses of radiation is not linear and that no increase in risk is 
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demonstrable at <100 mSv (REFS36,60) (FIG. 2). Thus, these data cannot be applied to 
medical imaging, which typically involves individual radiation exposures in this low range. 
However, even if the LNT hypothesis were to be used for estimating cancer risk (which we 
do not advocate), the estimated lifetime risk of cancer mortality from CT-related radiation is 
less than the lifetime risk of drowning (<0.1%)61. Furthermore, the majority of individuals 
receiving CT scans would probably die from the condition that prompted the CT 
examination long before a potential radiogenic cancer could arise47,62–65. Thus, estimating a 
potential increase in risk from medical radiation in a population of healthy individuals 
considerably overestimates risk when applied to a population with illnesses62. Additionally, 
the majority of individuals receiving CT in the USA are older than 60 years17. For example, 
data from the Mayo Clinic in the first quarter of 2016 showed that 51% of renal CT scans 
and CT urograms performed were on patients older than 60 years, whereas only 1% were in 
patients <19 years, 16% were in patients aged 20–39 years, and 32% were in patients aged 
40–59 years (A.F. and C.H.M, unpublished observations). Because the latency period 
between radiation exposure and the development of a radiogenic cancer is ~5–10 years for 
leukaemia (which affects predominantly young individuals) and 20–40 years for solid 
cancers17,54,66,67, potential cancers induced by a CT-related radiation exposure might not 
manifest in an individual’s lifetime, especially in the presence of other clinically significant 
disease.
Overall, current estimates of cancer risk from exposure to ionizing radiation derived from 
atomic bomb survivors provide a very conservative upper limit that is useful for radiation 
protection considerations, such as limiting occupational exposure and designing shielding 
around radiation areas. However, they are not appropriate for estimating population risks 
caused by the exposure to ionizing radiation at levels <100 mSv, such as are associated with 
CT scans.
Justifying CT in urological conditions
The International Commission on Radiological Protection (ICRP) describes the principle of 
justification as “any decision that alters the radiation exposure situation should do more 
good than harm”55. To justify exposing a patient to ionizing radiation, even if the risk is 
considered to be very low, the small theoretical risk of a future cancer induced by a 
medically indicated CT must be weighed against the immediate incremental benefit from 
undergoing such an examination47. For example, CT can be crucial for reducing mortality in 
patients with renal cell carcinoma, as cure is not possible unless the tumour and potential 
metastases can be diagnosed and treated68. Thus, the driving factor in a benefit-to-risk ratio 
analysis for imaging should be the potential benefit to the patient of undergoing the 
examination and not the low, theoretical cancer risk.
The most important method for reducing the risk associated with CT involves the 
elimination of inappropriate CT scans. Evidence-based recommendations, such as those 
provided by the American College of Radiology (ACR) and the European Association of 
Urology (EAU), provide detailed indications to facilitate appropriate referral for CT 
imaging5,69. Additionally, the use of computerized radiology order entry with decision 
support tools has been widely accepted by clinicians and has demonstrated a positive effect 
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on ordering practices70,71. With the use of these electronic tools, clinical practices such as 
those at the Massachusetts General Hospital and the University of Florida Health Center 
were able to achieve substantial decreases in CT volume growth and growth rate. For 
example, the University of Florida Health Center reported a significant (P < 0.001) reduction 
in the annual growth rate of outpatient CT following the implementation of a radiology order 
entry system with decision support tools — from 12% to 1% — despite a concomitant 
increase in outpatient visits of almost 5% per year71.
ACR appropriateness criteria
Currently, the ACR assigns each imaging modality an appropriateness rating by disease 
indication. The appropriateness criteria developed by the ACR for each topic include a 
systematic review of evidence, including a literature search, evidence table development and 
topic narrative review. The evidence tables include the study type, number of patients or 
events, study objectives and results, and study quality for each study evaluated from the 
literature. The narrative review consists of the summary of evidence, the variant tables that 
summarize the recommendations of the panel, a discussion of the medical literature and an 
evidence summary. Experts in interventional and diagnostic imaging, radiation oncology, 
and >20 medical specialty societies contributed to the development of the guidelines. An 
appropriateness rating of ≥7 means that the examination is a reasonable choice for 
evaluating that disease or injury. In the 2016 rankings, CT was considered an appropriate 
choice for 26 of 47 urological disorders and was the single most appropriate imaging 
technique for 18 of these 47 (REF5) (TABLE 2). The strength of evidence for each set of 
recommendations is summarized for each clinical indication and variant. For example, the 
ACR guidelines for ‘Acute Onset Flank Pain-Suspicion of Stone’ were based on 82 
references. These guidelines are considered to be thoroughly developed and clinically 
appropriate by the radiology community and the clinical experts who reviewed the available 
evidence, and remain current through the careful assessment of new literature and updates 
every 3 years.
EAU guidelines
The EAU releases updated guidelines on a yearly basis, striving to produce reports that are 
free from bias and to present a balanced view of risks and benefits. Moreover, the EAU 
ensures that both the clinical questions on which the recommendations are based and the 
outcomes of interest that are considered important take patient views into account.
Similar to the ACR appropriateness criteria5, the recommendations are assessed according to 
their level of evidence, and guidelines are given a grade of recommendation according to a 
classification system modified from the Oxford Centre for Evidence-Based Medicine Levels 
of Evidence69. Grade A implies that the recommendation was based on clinical studies of 
good quality and consistency, including at least one randomized trial. Grade B means that 
the recommendation was based on well-conducted clinical studies but without randomized 
clinical trials. Finally, grade C recommendations are made despite the absence of directly 
applicable clinical studies of good quality. In the 2016 extended guidelines, 18 clinical 
urological conditions were reviewed. Ofthose, ten had a recommendation for CT imaging in 
at least one clinical scenario (diagnostic evaluation, staging, management, or follow-up 
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monitoring). Out of 32 combined scenarios, 15 contained a recommendation for CT imaging 
(TABLE 3). When comparing and contrasting the recommendations from the ACR and 
EAU, the reader can observe substantial agreement for the appropriate use of CT imaging 
across different clinical conditions.
Common clinical nephrourological scenarios
CT is strongly justified and frequently used in many common urological clinical scenarios, 
as outlined in the guidelines. Five particularly common scenarios include urinary stone 
disease, painless haematuria, characterization of an incidentally found renal mass, 
renovascular hypertension, and evaluation of a potential renal donor.
Urinary stone disease
Unenhanced CT has replaced intravenous pyelography (IVP) as the imaging method of 
choice for a patient presenting with flank pain, owing to its sensitivity, specificity, and 
accuracy of >95%6 (ACR appropriateness criteria score of 8). IVP is no longer even 
included in the appropriateness guidelines because of the diagnostic superiority of CT. 
Among patients with recurrent symptoms of stone disease, either unenhanced CT or Doppler 
ultrasonography of the kidneys and bladder could be obtained (ACR appropriateness criteria 
score of 7 for both). These recommendations are based on the high likelihood of a stone, 
which make it appropriate to use ultrasonography to confirm the presence of a stone, as this 
modality does not use ionizing radiation. If ultrasonography is inconclusive, CT would then 
be performed, as it is more sensitive and can examine the entire abdomen and pelvis. For 
pregnant patients, Doppler is preferred to CT as the first imaging technique (ACR 
appropriateness criteria of 8 and 6, respectively). Limiting the CT imaging to only the 
necessary anatomy is key to reducing radiation exposure. For instance, in a study to 
determine if a patient has passed a distal ureteral stone, the inclusion of the abdomen in the 
scan range might not be appropriate, as the stone is known to be within the pelvis. This 
concept is included in the American Urological Association (AUA) guidelines on the 
surgical management of stones14.
Once a stone is detected, data derived from CT have an important role in deciding treatment 
options. If the stone is large and unlikely to pass and surgery is considered, a non-contrast 
CT scan of the abdomen and pelvis is essential for appropriate surgical planning14. 
Furthermore, the AUA guidelines for managing renal stones note that in cases of altered 
anatomy, such as calyceal diverticulum, horseshoe kidney, or ureteral duplication, contrast-
enhanced images in the form of a CT urogram or IVP can be of benefit14. Determination of 
stone composition with dual-energy CT might also be helpful in determining treatment 
options72. For example, uric acid stones respond to urine alkalinization, whereas other types 
of stones, including cystine, calcium oxalate monohydrate, and brushite, are resistant to 
shockwave lithotripsy and would be better treated with ureteroscopic stone extraction or 
percutaneous nephrolithotomy14,73.
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Painless haematuria
Haematuria is one of the most common urological presentations, with a prevalence of 4% in 
the adult population74. The role of imaging in patients presenting with haematuria is to 
detect renal tumours, transitional cell carcinoma in the upper urinary tract, urinary tract 
stones, and renal infection after ruling out primary renal parenchymal disease75. CT 
urography is now considered the modality of choice for patients with haematuria and is 
recommended by both the ACR76 (appropriateness criteria score of 9) and the EAU 
guidelines69, owing to the significantly higher accuracy for the detection of urothelial 
carcinoma using CT than with an intravenous urogram (IVU) (94% versus 81%, P = 
0.001)77.
Incidental renal mass
Ultrasonography provides the most cost-effective method of defining and confirming a 
benign cyst, which, with a prevalence rate of 2.7% in individuals younger than 40 years and 
23.9% in those older than 60 years, is the most common renal mass78,79. The cost of 
ultrasonography — $116 according to the 2018 Medicare Reimbursement Fee — is 
considerably lower than that of a CT scan ($267). CT is the modality of choice for 
evaluating indeterminate renal lesions that are suspicious for malignancy (ACR 
appropriateness criteria score of 9), except for in patients with renal insufficiency, for which 
ultrasonography (score of 8) and MRI (score of 7) are preferred to CT (score of 5) because 
intravenous iodinated contrast is contraindicated in patients with compromised renal 
function80.
Renovascular hypertension
Renovascular hypertension, caused by reduced perfusion pressure to one or both kidneys, is 
most commonly associated with underlying renal artery stenosis81. Both magnetic resonance 
angiography (MRA) and CTA are suitable for noninvasive work-up of renal artery stenosis, 
as they enable detailed inspection of the renal arteries (ACR appropriateness criteria score of 
8 (REF82)). As the diagnostic accuracies of these techniques are similar83, other 
considerations, such as timely appointment access, difference in cost (Medicare 
reimbursement for renal MRA is $411, whereas for CTA it is $313)84, difference in 
examination length (MRA typically lasts for 45–60 minutes, whereas CTA lasts 15 minutes 
or less), and claustrophobia (the MR gantry opening is typically 60–70 cm wide and 2 m 
long, whereas a CT gantry is typically 70–80 cm wide and <1 m long), must be taken into 
consideration.
Evaluation of a potential renal donor
The role of imaging in potential renal donors includes evaluation of renal vascular anatomy 
and exclusion of any urinary tract disease (stone disease, renal or urothelial tumour, and 
renal vascular disease)85. Both CTA and MRA have been used for the evaluation of potential 
renal donors. A study by Glueker et al.86 that included 48 potential living renal donors 
undergoing CTA and gadolinium-enhanced MRA revealed substantial equivalence in 
depicting vascular anatomy. The advantages of CTA are its ability to detect urinary stones 
and vascular calcifications, reduced susceptibility to motion artefacts, and increased spatial 
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resolution, whereas MRA has better contrast sensitivity, which usually removes the need for 
exogenous contrast agents in MRA.
Optimizing CT for urological conditions
The second fundamental principle of radiation protection in medicine is that medically 
justified exams should be technically optimized. The ICRP describes optimization as 
ensuring that, commensurate with the requirements of the medical exam or procedure, “the 
likelihood of incurring exposure, the number of people exposed, and the magnitude of their 
individual doses should all be kept as low as reasonably achievable, taking into account 
economic and societal factors”55. Optimization of CT protocols implies that the radiation 
dose is kept as low as possible without compromising the diagnostic quality of the image87. 
The radiology community has worked with industry partners to implement these principles 
in CT imaging88,89. As a result of these efforts, the radiation doses associated with CT have 
been reduced considerably over the past 40 years, and, currently, most CT scans of the 
kidneys and urinary tract result in radiation doses comparable to the annual background 
radiation levels (FIGS 3,4). Notably, even as doses have fallen, image quality has increased 
substantially. Early CT scans in the 1970s to 1980s used 10 mm-thick images, whereas 
today, CT images in the abdomen and pelvis are 2–5 mm thick. As the image thickness 
decreases, the conspicuity of small pathology, such as small urinary stones, increases 
dramatically. With current technology, even multiphase urograms result in effective doses 
that are well below the annual dose limit for radiation workers (50 mSv)90 (FIG. 4).
Strategies can be implemented to substantially reduce radiation exposure for 
nephrourological CT examinations without compromising diagnostic quality, as 
technological advances in CT imaging have resulted in scans that are faster, lower in dose, 
and of higher quality than ever before. Optimization of CT scanning for the specific 
diagnostic task is essential to ensure that images of adequate diagnostic quality are 
produced, regardless of patient size or condition, with the minimum necessary dose of 
radiation.
Adjusting tube potential and current
Tube current, which is linearly related to the applied radiation dose, should be adjusted to 
most efficiently deliver the required radiation dose as a function of patient size at each 
anatomical level that is scanned. Patient size in modern CT scanners is automatically 
assessed by the scanner on the basis of information contained in the CT localizer radiograph 
performed before the CT scan.
Reducing the tube potential in CT examinations that use iodinated contrast media enables 
minimization of the radiation dose while maintaining diagnostic quality, owing to the 
improved conspicuity of hypervascular or hypovascular pathologies when iodinated contrast 
is used91. For paediatric patients, the noise level does not increase with the decrease in tube 
potential, resulting in a much stronger dose reduction with low-tube-potential imaging in 
children than in adult patients92,93.
Ferrero et al. Page 11
Nat Rev Urol. Author manuscript; available in PMC 2019 April 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Iterative reconstruction
All major CT manufacturers now offer the option of iterative reconstruction, which aims to 
substantially reduce the radiation dose while maintaining adequate image quality. Analytical 
reconstruction algorithms, such as filtered backprojection (FBP), have been the primary 
method for creating images from the measured attenuation data since CT was in its infancy 
in the early 1970s. The single-step FBP approach is very fast, but does not consider other 
existing information, such as which measurements are more reliable than others or 
information about the scanner characteristics. In iterative reconstruction methods, the initial 
FBP-reconstructed images are progressively (iteratively) refined to improve the agreement 
between the actually acquired X-ray attenuation measurements and attenuation 
measurements synthesized from the reconstructed image. If the measured and synthesized 
attenuation data are not in good agreement, the reconstructed image is modified over and 
over until satisfactory agreement is achieved.
For diagnostic tasks involving high-contrast anatomic structures or pathology, such as 
visualization of iodinated contrast material in vascular structures or the detection of urinary 
stones, substantial noise reduction — and, consequently, radiation dose reduction — is made 
possible by iterative reconstruction methods without compromising diagnostic 
performance94. However, dose reductions by >25% have been shown to reduce diagnostic 
performance for tasks that involve the detection of low-contrast targets95, such as the 
differentiation of renal cell carcinoma from hyperproteic renal cysts. Thus, leveraging 
iterative reconstruction to dramatically reduce radiation dose should be done cautiously and 
with consideration of the diagnostic requirements of a specific scan.
Dual-energy CT
Advances in CT technology over the past decade have made dual-energy CT (DECT), which 
was first suggested in 1973, a viable clinical option96. In DECT, two CT data sets are 
acquired, which correspond to the X-ray attenuation from lower-energy and higher-energy 
X-rays. These two data sets are then manipulated to extract information about the 
contributions of different materials to each voxel in the CT volume. In addition to the 
classification of renal stone types, DECT has shown potential for the characterization of 
renal and adrenal masses97. Furthermore, material decomposition techniques enable the 
creation of virtual non-contrast images from data acquired after a contrast injection. If 
equivalent diagnostic performance can be achieved, for example, for the detection of urinary 
stones with virtual non-contrast images, the true non-contrast CT acquisition in multiphase 
examinations could be elimi-nated98. Because DECT can be performed at similar radiation 
dose levels as single-energy CT99, eliminating the true non-contrast phase might result in a 
reduction of dose in multiphase CT examinations98.
Imaging of pregnant patients
Pregnancy is known to alter the anatomy and physiology of the urinary system100. 
Hydroureter and hydronephrosis have been reported to be the most common urological 
diseases in pregnant patients, accounting for >60% of all urological conditions in pregnant 
patients100. Calculi in the renal system or urinary tract are the second most common 
urological concern in pregnant women100. Regardless of the clinical indication for CT in a 
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pregnant patient, the scan volume should be restricted to the necessary anatomy, and 
multiphase (with and without contrast) studies should be avoided in patients with 
uncomplicated renal colic.
The small amount of risk to the baby should be weighed against the potential benefit of the 
acquired information for the care of the mother (which will also benefit the baby). Even if a 
biphase CT scan of the abdomen and pelvis is obtained in a pregnant patient, which directly 
irradiates the baby twice, the probability of successfully delivering a healthy baby (with no 
abnormalities or malformations) decreases by only 0.1%, from 96.00% to 95.90%, and the 
probability that the baby will be born healthy and not develop childhood cancer decreases by 
only 0.5%, from 95.93% to 95.43%101. To put the significance of these relatively small risks 
into context, in 2016, Rossen et al.102 reported a 50% higher infant mortality for black 
infants than for white infants in the USA, 10–50 times higher than the relative risks 
described for exposure to an abdominal CT scan during pregnancy. Thus, the small potential 
risks from in utero exposure to ionizing radiation must be evaluated in terms of overall risks 
to the mother and baby, with consideration of the potential benefits of the information 
obtained using CT, and with comparison to the risks, benefits, availability, and costs of other 
available imaging modalities, such as ultrasonography and MRI. For example, both 
ultrasonography and MRI are less sensitive and specific for stone disease relative to CT. 
Furthermore, ultrasonography has been shown to overestimate stone size relative to the 
reference standard (CT), and pregnancy can exacerbate the decreased accuracy of 
ultrasonography owing to changes in ureter dimensions during pregnancy103–105.
Conclusions
Guidelines from leading professional organizations, including the ACR and the EAU, 
demonstrate that CT imaging is essential in evaluating nephrourological conditions. 
However, concerns about the use of ionizing radiation in medical imaging, particularly the 
use of CT, remain, even though the doses from CT are similar to background doses of 
radiation from naturally occurring sources (1–20 mSv). The fact is that despite nearly a 
century of intensive study, conclusive evidence is lacking to prove that an increased risk of 
cancer exists for radiation doses less than ~100 mSv. In response to the concerns that have 
been raised, numerous efforts have been made to further reduce the doses associated with 
CT scanning, with the result that CT scans are now performed at doses 40% less than those 
required in 2000.
The principles of justification and optimization of the ICRP remain the basis for the use of 
ionizing radiation in medicine, regardless of whether the debate about potential risks 
associated with low doses of radiation is ever resolved. These principles state that when an 
examination is justified (that is, deemed medically appropriate), it should be performed, and 
when it is performed, the examination should be optimized (that is, performed using the 
lowest radiation dose that is consistent with achieving the necessary diagnostic information). 
Because the potential risks associated with the low doses of ionizing radiation used in CT 
imaging are very low and might, in fact, not even exist, the overriding factor for deciding 
whether or not a CT examination should be performed is the proven clinical benefits of CT 
scanning. If the CT examination will provide information that could benefit the care of the 
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patient, the CT should be obtained, using optimized techniques, as the potential large benefit 
to an individual patient exceeds that of any small potential risk to that patient.
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Key points
• CT scans are commonly performed in nephrourology, for indications 
including suspected stones and renal masses.
• Concerns have been raised regarding the potential harmful effects of exposure 
to radiation associated with CT scans; however, the dose associated with CT 
is <~100 mSv and no harmful effects have been shown at these low doses.
• Even taking the very low potential risk of malignancy into account, such a 
risk must be considered in the context of the clinical benefit of performing the 
scan, and elimination of unnecessary CT examinations is the first step towards 
managing risk.
• Optimization of the scanning technique is essential, so that the necessary 
clinical information can be gathered with minimization of the radiation dose.
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Fig. 1|. Illustration of the different models for radiation-related cancer risk as a function of 
radiation dose in the low-dose (<100 mSv) region.
Convincing and consistent evidence of risk in this low-dose region has to date not been 
provided despite more than a century of investigation into the biological effects of ionizing 
radiation. Reasons for this lack of evidence include the statistical inability to detect a tiny 
increase in cancer incidence or mortality against the existing large background rate for 
cancer incidence or mortality and the fact that radiogenic cancers cannot be differentiated 
from naturally occurring cancers or cancers due to other factors. Furthermore, there are data 
that suggest different relationships exist for different types of cancers. Thus, these models 
are unlikely to ever be unequivocally validated. a.u., arbitrary unit.
Ferrero et al. Page 20
Nat Rev Urol. Author manuscript; available in PMC 2019 April 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2|. Cancer incidence as a function of effective radiation dose for survivors of the atomic 
bombings in Japan.
An increase in cancer incidence above that of unexposed individuals was observed only for 
survivors exposed to >100 mSv (square data point represents inhabitants of Hiroshima and 
Nagasaki not present in the two towns at the time of the bombings). Data from Preston et al.
36
.
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Fig. 3|. Typical dose levels (in terms of effective dose) for a routine CT examination of the 
abdomen and pelvis over various time periods.
Owing to concerted efforts from the radiology community, the radiation associated with CT 
has been reduced considerably over the past 40 years and most CT scans of the kidneys and 
urinary tract now result in radiation doses comparable to the annual background radiation.
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Fig. 4|. Typical effective doses for common imaging examinations that use ionizing radiation.
Bars represent the 25–75 percentile from the American College of Radiology Dose Index 
Registry (DIR) participating sites (third to fourth quarter, 2017). For examinations for which 
the DIR did not provide reference values, typical effective doses from our large clinical 
practice were used. All effective doses fall below the annual dose limit for radiation workers.
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